ArticlePharmaceuticals (Basel, Switzerland)2024

Hesperidin Nanoformulation: A Potential Strategy for Reducing Doxorubicin-Induced Renal Damage via the Sirt-1/HIF1-α/VEGF/NF-κB Signaling Cascade.

Fatemah A Alherz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.